Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-10-15 06:59 am Purchase | 13G | ELUTIA INC. ELUT | SILVERARC CAPITAL MANAGEMENT LLC | 1,645,808 5.530% | 1,645,808 (New Position) | View |
2024-10-15 06:55 am Sale | 13G | MERSANA THERAPEUTICS INC MRSN | SILVERARC CAPITAL MANAGEMENT LLC | 1,754,086 1.430% | -4,666,050 (-72.68%) | View |
2024-10-15 06:52 am Sale | 13G | EVOGENE LTD EVGN | SILVERARC CAPITAL MANAGEMENT LLC | 307,972 3.520% | -2,792,028 (-90.07%) | View |
2024-02-14 8:43 pm Purchase | 13G | MERSANA THERAPEUTICS INC MRSN | SILVERARC CAPITAL MANAGEMENT LLC | 6,420,136 5.300% | 6,420,136 (New Position) | View |
2024-02-14 8:39 pm Purchase | 13G | MOLECULAR TEMPLATES INC NE MTEM | SILVERARC CAPITAL MANAGEMENT LLC | 354,608 6.600% | 354,608 (New Position) | View |
2024-02-14 8:30 pm Purchase | 13G | EVOGENE LTD EVGN | SILVERARC CAPITAL MANAGEMENT LLC | 3,100,000 6.100% | 3,100,000 (New Position) | View |
2023-02-07 5:38 pm Sale | 13G | Benitec Biopharma Inc. BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 0 0.000% | -587,499 (Position Closed) | View |
2022-02-10 09:09 am Unchanged | 13G | Benitec Biopharma Inc. BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 587,499 7.200% | 0 (Unchanged) | View |
2022-02-10 09:07 am Unchanged | 13G | Benitec Biopharma Inc. BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 587,499 7.200% | 0 (Unchanged) | View |
2022-02-09 4:39 pm Purchase | 13G | Benitec Biopharma Inc. BNTC | SILVERARC CAPITAL MANAGEMENT LLC | 587,499 7.200% | 587,499 (New Position) | View |
2022-02-08 4:48 pm Sale | 13G | DELCATH SYS INC DCTH | SILVERARC CAPITAL MANAGEMENT LLC | 0 0.000% | -351,616 (Position Closed) | View |
2021-03-10 11:19 am Purchase | 13G | DELCATH SYS INC DCTH | SILVERARC CAPITAL MANAGEMENT LLC | 351,616 5.900% | 351,616 (New Position) | View |